STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,424,912 | -62.4% | 1,630,688 | +1.5% | 0.00% | – |
| Q2 2023 | $17,080,114 | +81.1% | 1,606,784 | +41.9% | 0.00% | – |
| Q1 2023 | $9,429,452 | -36.2% | 1,131,987 | -29.3% | 0.00% | – |
| Q4 2022 | $14,786,876 | -43.8% | 1,602,045 | -21.8% | 0.00% | -100.0% |
| Q3 2022 | $26,295,000 | -0.2% | 2,047,904 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $26,354,000 | -35.4% | 1,995,033 | +2.9% | 0.00% | 0.0% |
| Q1 2022 | $40,824,000 | -11.0% | 1,939,390 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $45,873,000 | -2.4% | 1,912,182 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $47,003,000 | -19.7% | 1,847,615 | +6.3% | 0.00% | 0.0% |
| Q2 2021 | $58,527,000 | -9.3% | 1,738,802 | +4.7% | 0.00% | -50.0% |
| Q1 2021 | $64,514,000 | -35.1% | 1,661,011 | +3.4% | 0.00% | -33.3% |
| Q4 2020 | $99,475,000 | +127.4% | 1,606,268 | +23.0% | 0.00% | +200.0% |
| Q3 2020 | $43,737,000 | +43.6% | 1,305,960 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $30,462,000 | +67.1% | 1,278,341 | +60.6% | 0.00% | 0.0% |
| Q1 2020 | $18,229,000 | -16.7% | 795,990 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $21,886,000 | +51.2% | 772,804 | +14.7% | 0.00% | 0.0% |
| Q3 2019 | $14,476,000 | +396.3% | 673,584 | +573.6% | 0.00% | – |
| Q2 2019 | $2,917,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |